Background/Purpose: Diabetes affects over 537 million people worldwide and is projected to reach 783 million by 2045. Early risk stratification can benefit from machine learning. We compare two hybrid classifiers and assess their generalizability on an external cohort. Methods: Two hybrids were built: (i) XGBoost + Random Forest (XGB-RF) and (ii) Support Vector Machine + Logistic Regression (SVM-LR). A leakage-safe, standardized pipeline (encoding, imputation, min-max scaling; SMOTE on training folds only; probability calibration for SVM) was fit on the primary dataset and frozen. Evaluation prioritized threshold-independent discrimination (AUROC/AUPRC) and calibration (Brier, slope/intercept). External validation used the PIMA cohort (N=768) with the frozen pipeline; any thresholded metrics on PIMA were computed at the default rule tau = 0.5. Results: On the primary dataset (PR baseline = 0.50), XGB-RF achieved AUROC ~0.995 and AUPRC ~0.998, outperforming SVM-LR (AUROC ~0.978; AUPRC ~0.947). On PIMA (PR baseline ~0.349), XGB-RF retained strong performance (AUROC ~0.990; AUPRC ~0.959); SVM-LR was lower (AUROC ~0.963; AUPRC ~0.875). Thresholded metrics on PIMA at tau = 0.5 were XGB-RF (Accuracy 0.960; Precision 0.941; Recall 0.944; F1 0.942) and SVM-LR (Accuracy 0.900; Precision 0.855; Recall 0.858; F1 0.857). Conclusions: Across internal and external cohorts, XGB-RF consistently dominated SVM-LR and exhibited smaller external attenuation on ROC/PR with acceptable calibration. These results support gradient-boosting-based hybridization as a robust, transferable approach for diabetes risk stratification and motivate prospective, multi-site validation with deployment-time threshold selection based on clinical trade-offs.

Graph-level anomaly detection (GAD) is critical in diverse domains such as drug discovery, yet high labeling costs and dataset imbalance hamper the performance of Graph Neural Networks (GNNs). To address these issues, we propose FracAug, an innovative plug-in augmentation framework that enhances GNNs by generating semantically consistent graph variants and pseudo-labeling with mutual verification. Unlike previous heuristic methods, FracAug learns semantics within given graphs and synthesizes fractional variants, guided by a novel weighted distance-aware margin loss. This captures multi-scale topology to generate diverse, semantic-preserving graphs unaffected by data imbalance. Then, FracAug utilizes predictions from both original and augmented graphs to pseudo-label unlabeled data, iteratively expanding the training set. As a model-agnostic module compatible with various GNNs, FracAug demonstrates remarkable universality and efficacy: experiments across 14 GNNs on 12 real-world datasets show consistent gains, boosting average AUROC, AUPRC, and F1-score by up to 5.72%, 7.23%, and 4.18%, respectively.

Recent progress in large language models (LLMs) has enabled the automated processing of lengthy documents even without supervised training on a task-specific dataset. Yet, their zero-shot performance in complex tasks as opposed to straightforward information extraction tasks remains suboptimal. One feasible approach for tasks with lengthy, complex input is to first summarize the document and then apply supervised fine-tuning to the summary. However, the summarization process inevitably results in some loss of information. In this study we present a method for processing the summaries of long documents aimed to capture different important aspects of the original document. We hypothesize that LLM summaries generated with different aspect-oriented prompts contain different \textit{information signals}, and we propose methods to measure these differences. We introduce approaches to effectively integrate signals from these different summaries for supervised training of transformer models. We validate our hypotheses on a high-impact task -- 30-day readmission prediction from a psychiatric discharge -- using real-world data from four hospitals, and show that our proposed method increases the prediction performance for the complex task of predicting patient outcome.

Node Anomaly Detection (NAD) has gained significant attention in the deep learning community due to its diverse applications in real-world scenarios. Existing NAD methods primarily embed graphs within a single Euclidean space, while overlooking the potential of non-Euclidean spaces. Besides, to address the prevalent issue of limited supervision in real NAD tasks, previous methods tend to leverage synthetic data to collect auxiliary information, which is not an effective solution as shown in our experiments. To overcome these challenges, we introduce a novel SpaceGNN model designed for NAD tasks with extremely limited labels. Specifically, we provide deeper insights into a task-relevant framework by empirically analyzing the benefits of different spaces for node representations, based on which, we design a Learnable Space Projection function that effectively encodes nodes into suitable spaces. Besides, we introduce the concept of weighted homogeneity, which we empirically and theoretically validate as an effective coefficient during information propagation. This concept inspires the design of the Distance Aware Propagation module. Furthermore, we propose the Multiple Space Ensemble module, which extracts comprehensive information for NAD under conditions of extremely limited supervision. Our findings indicate that this module is more beneficial than data augmentation techniques for NAD. Extensive experiments conducted on 9 real datasets confirm the superiority of SpaceGNN, which outperforms the best rival by an average of 8.55% in AUC and 4.31% in F1 scores. Our code is available at https://github.com/xydong127/SpaceGNN.

The imperative for early detection of type 2 diabetes mellitus (T2DM) is challenged by its asymptomatic onset and dependence on suboptimal clinical diagnostic tests, contributing to its widespread global prevalence. While research into noninvasive T2DM screening tools has advanced, conventional machine learning approaches remain limited to unimodal inputs due to extensive feature engineering requirements. In contrast, deep learning models can leverage multimodal data for a more holistic understanding of patients' health conditions. However, the potential of chest X-ray (CXR) imaging, one of the most commonly performed medical procedures, remains underexplored. This study evaluates the integration of CXR images with other noninvasive data sources, including electronic health records (EHRs) and electrocardiography signals, for T2DM detection. Utilising datasets meticulously compiled from the MIMIC-IV databases, we investigated two deep fusion paradigms: an early fusion-based multimodal transformer and a modular joint fusion ResNet-LSTM architecture. The end-to-end trained ResNet-LSTM model achieved an AUROC of 0.86, surpassing the CXR-only baseline by 2.3% with just 9863 training samples. These findings demonstrate the diagnostic value of CXRs within multimodal frameworks for identifying at-risk individuals early. Additionally, the dataset preprocessing pipeline has also been released to support further research in this domain.

Developing therapeutics is a lengthy and expensive process that requires the satisfaction of many different criteria, and AI models capable of expediting the process would be invaluable. However, the majority of current AI approaches address only a narrowly defined set of tasks, often circumscribed within a particular domain. To bridge this gap, we introduce Tx-LLM, a generalist large language model (LLM) fine-tuned from PaLM-2 which encodes knowledge about diverse therapeutic modalities. Tx-LLM is trained using a collection of 709 datasets that target 66 tasks spanning various stages of the drug discovery pipeline. Using a single set of weights, Tx-LLM simultaneously processes a wide variety of chemical or biological entities(small molecules, proteins, nucleic acids, cell lines, diseases) interleaved with free-text, allowing it to predict a broad range of associated properties, achieving competitive with state-of-the-art (SOTA) performance on 43 out of 66 tasks and exceeding SOTA on 22. Among these, Tx-LLM is particularly powerful and exceeds best-in-class performance on average for tasks combining molecular SMILES representations with text such as cell line names or disease names, likely due to context learned during pretraining. We observe evidence of positive transfer between tasks with diverse drug types (e.g.,tasks involving small molecules and tasks involving proteins), and we study the impact of model size, domain finetuning, and prompting strategies on performance. We believe Tx-LLM represents an important step towards LLMs encoding biochemical knowledge and could have a future role as an end-to-end tool across the drug discovery development pipeline.

Multimodal machine learning with missing modalities is an increasingly relevant challenge arising in various applications such as healthcare. This paper extends the current research into missing modalities to the low-data regime, i.e., a downstream task has both missing modalities and limited sample size issues. This problem setting is particularly challenging and also practical as it is often expensive to get full-modality data and sufficient annotated training samples. We propose to use retrieval-augmented in-context learning to address these two crucial issues by unleashing the potential of a transformer's in-context learning ability. Diverging from existing methods, which primarily belong to the parametric paradigm and often require sufficient training samples, our work exploits the value of the available full-modality data, offering a novel perspective on resolving the challenge. The proposed data-dependent framework exhibits a higher degree of sample efficiency and is empirically demonstrated to enhance the classification model's performance on both full- and missing-modality data in the low-data regime across various multimodal learning tasks. When only 1% of the training data are available, our proposed method demonstrates an average improvement of 6.1% over a recent strong baseline across various datasets and missing states. Notably, our method also reduces the performance gap between full-modality and missing-modality data compared with the baseline.

Time-series anomaly detection deals with the problem of detecting anomalous timesteps by learning normality from the sequence of observations. However, the concept of normality evolves over time, leading to a "new normal problem", where the distribution of normality can be changed due to the distribution shifts between training and test data. This paper highlights the prevalence of the new normal problem in unsupervised time-series anomaly detection studies. To tackle this issue, we propose a simple yet effective test-time adaptation strategy based on trend estimation and a self-supervised approach to learning new normalities during inference. Extensive experiments on real-world benchmarks demonstrate that incorporating the proposed strategy into the anomaly detector consistently improves the model's performance compared to the baselines, leading to robustness to the distribution shifts.

Self-supervised learning has emerged as a highly effective approach in the fields of natural language processing and computer vision. It is also applicable to brain signals such as electroencephalography (EEG) data, given the abundance of available unlabeled data that exist in a wide spectrum of real-world medical applications ranging from seizure detection to wave analysis. The existing works leveraging self-supervised learning on EEG modeling mainly focus on pretraining upon each individual dataset corresponding to a single downstream task, which cannot leverage the power of abundant data, and they may derive sub-optimal solutions with a lack of generalization. Moreover, these methods rely on end-to-end model learning which is not easy for humans to understand. In this paper, we present a novel EEG foundation model, namely EEGFormer, pretrained on large-scale compound EEG data. The pretrained model cannot only learn universal representations on EEG signals with adaptable performance on various downstream tasks but also provide interpretable outcomes of the useful patterns within the data. To validate the effectiveness of our model, we extensively evaluate it on various downstream tasks and assess the performance under different transfer settings. Furthermore, we demonstrate how the learned model exhibits transferable anomaly detection performance and provides valuable interpretability of the acquired patterns via self-supervised learning.

Intensive Care Units usually carry patients with a serious risk of mortality. Recent research has shown the ability of Machine Learning to indicate the patients' mortality risk and point physicians toward individuals with a heightened need for care. Nevertheless, healthcare data is often subject to privacy regulations and can therefore not be easily shared in order to build Centralized Machine Learning models that use the combined data of multiple hospitals. Federated Learning is a Machine Learning framework designed for data privacy that can be used to circumvent this problem. In this study, we evaluate the ability of deep Federated Learning to predict the risk of Intensive Care Unit mortality at an early stage. We compare the predictive performance of Federated, Centralized, and Local Machine Learning in terms of AUPRC, F1-score, and AUROC. Our results show that Federated Learning performs equally well as the centralized approach and is substantially better than the local approach, thus providing a viable solution for early Intensive Care Unit mortality prediction. In addition, we show that the prediction performance is higher when the patient history window is closer to discharge or death. Finally, we show that using the F1-score as an early stopping metric can stabilize and increase the performance of our approach for the task at hand.